Document Detail


Recent and future advances in the treatment of PMS, PMD, and menopause.
MedLine Citation:
PMID:  15931569     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
In keeping with the widespread demand for therapy, many different ways of dealing with premenstrual syndrome (PMS), premenstrual dysphoria (PMD) and post menopausal symptoms are presently recommended and practiced. Severe depression associated with PMD is often treated with selective serotonin reuptake inhibitors (SSRI), while milder PMS often receives a number of medical and alternate remedies. Post menopausal symptoms are often avoided by use of hormone replacement therapy (HRT), alternatives for which include natural hormone replacement therapy (nHRT). Alternate therapies and interventions are also practiced widely. The continued need for improved therapies should lead to more extensive consideration of hormone metabolism which is greatly altered by exercise and dietary factors. A full knowledge of the hormone metabolic path from cause to effect is urgently required.
Authors:
G M Andrus
Related Documents :
1753739 - Exercise and migraine. a critical review.
15907979 - Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocyt...
17870419 - The effect of combining manual therapy with exercise on the respiratory function of nor...
18461499 - The effects of exercise upon symptoms and quality of life in patients diagnosed with ir...
16084749 - Exercise therapy for low back pain: a small-scale exploratory survey of current physiot...
11340799 - The efficacy of oro-facial and articulation exercises in dysarthria following stroke.
8338039 - Resting metabolic rate measured after subjects spent the night at home vs at a clinic.
22654999 - The effect of exercise on pulpal and gingival blood flow in physically active and inact...
17548549 - A randomized controlled trial of resistance exercise in individuals with als.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  IDrugs : the investigational drugs journal     Volume:  4     ISSN:  1369-7056     ISO Abbreviation:  IDrugs     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2005-06-02     Completed Date:  2005-08-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883655     Medline TA:  IDrugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  1373-81     Citation Subset:  -    
Affiliation:
Designed Nutritional Products, PO Box 1242, Orem, UT 84059-1242, USA. theranat@itsnet.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Organic process research and development--fifth international conference.
Next Document:  Inhibition of farnesyl protein transferase--a review of the recent patent literature.